SCHW
52
3
AVB
65
-2
GM
58
-2
QCOM
55
-4
ADI
59
-2
WMB
60
4
PFE
30
-3
BF.B
43
-7
JBHT
50
-6
CL
58
2
LEN
55
-9
AEP
58
2
FLR
52
4
NRG
69
12
SWK
81
-3
BIIB
37
7
TXN
50
-3
O
31
3
TAP
45
-6
WEC
45
2
SCHW
52
3
AVB
65
-2
GM
58
-2
QCOM
55
-4
ADI
59
-2
WMB
60
4
PFE
30
-3
BF.B
43
-7
JBHT
50
-6
CL
58
2
LEN
55
-9
AEP
58
2
FLR
52
4
NRG
69
12
SWK
81
-3
BIIB
37
7
TXN
50
-3
O
31
3
TAP
45
-6
WEC
45
2
Financhill
Back

Mawson Infrastructure Group Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
32

MIGI
Mawson Infrastructure Group

Last Price:
1.22
Seasonality Move:
-25.38%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
32
Mawson Infrastructure Group (MIGI) is a Sell

Is Mawson Infrastructure Group a Buy, Sell or Hold?

  • The current Mawson Infrastructure Group [MIGI] share price is $1.22. The Score for MIGI is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • MIGI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MIGI Stock Price Chart

What is Mawson Infrastructure Group's stock price today?

  • The Mawson Infrastructure Group share price today is $1.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIGI is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

MIGI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 46.62 Sell
Chaikin Money Flow: -31857 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.17 - 1.47) Sell
Bollinger Bands (100): (1.12 - 1.56) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

MIGI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.22 Sell
20-day SMA: 1.29 Sell
50-day SMA: 1.34 Sell
200-day SMA: 1.6 Sell
8-day EMA: 1.23 Sell
20-day EMA: 1.26 Sell
50-day EMA: 1.32 Sell
200-day EMA: 1.57 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Mawson Infrastructure Group Earnings Growth & MIGI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.31 per share, an increase this year of $1.78 per share, and an increase next year of $2.03 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Mawson Infrastructure Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):